David Wifling

575 total citations
16 papers, 275 citations indexed

About

David Wifling is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, David Wifling has authored 16 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Immunology. Recurrent topics in David Wifling's work include Receptor Mechanisms and Signaling (14 papers), Chemical Synthesis and Analysis (8 papers) and Mast cells and histamine (7 papers). David Wifling is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Chemical Synthesis and Analysis (8 papers) and Mast cells and histamine (7 papers). David Wifling collaborates with scholars based in Germany, Austria and United States. David Wifling's co-authors include Günther Bernhardt, Armin Buschauer, Max Keller, Peter Gmeiner, Timothy Clark, Harald Hübner, Stefan Dove, Roland Seifert, Sigurd Elz and Steffen Pockes and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

David Wifling

16 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wifling Germany 12 244 119 72 38 25 16 275
Joëlle Goulding United Kingdom 8 320 1.3× 134 1.1× 30 0.4× 35 0.9× 31 1.2× 18 380
Heng B. See Australia 11 346 1.4× 139 1.2× 33 0.5× 34 0.9× 42 1.7× 14 410
Mark Soave United Kingdom 11 226 0.9× 99 0.8× 25 0.3× 51 1.3× 21 0.8× 17 282
Changxiu Qu China 7 260 1.1× 122 1.0× 50 0.7× 32 0.8× 17 0.7× 9 327
Shane C. Wright Sweden 11 375 1.5× 164 1.4× 21 0.3× 37 1.0× 25 1.0× 15 427
John Frazer United States 8 239 1.0× 99 0.8× 22 0.3× 39 1.0× 14 0.6× 15 361
Yangxia Tan China 7 286 1.2× 127 1.1× 27 0.4× 46 1.2× 26 1.0× 10 343
Tamara Miljuš United Kingdom 5 334 1.4× 190 1.6× 24 0.3× 54 1.4× 18 0.7× 9 389
Lukas Grätz Germany 10 216 0.9× 95 0.8× 44 0.6× 25 0.7× 16 0.6× 26 246
Timo Littmann Germany 11 183 0.8× 136 1.1× 30 0.4× 19 0.5× 6 0.2× 17 227

Countries citing papers authored by David Wifling

Since Specialization
Citations

This map shows the geographic impact of David Wifling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wifling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wifling more than expected).

Fields of papers citing papers by David Wifling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wifling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wifling. The network helps show where David Wifling may publish in the future.

Co-authorship network of co-authors of David Wifling

This figure shows the co-authorship network connecting the top 25 collaborators of David Wifling. A scholar is included among the top collaborators of David Wifling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wifling. David Wifling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wifling, David, et al.. (2021). Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2R selectivity. European Journal of Medicinal Chemistry. 213. 113159–113159. 5 indexed citations
2.
Grätz, Lukas, Maximilian F. Schmidt, Anselm H. C. Horn, et al.. (2021). N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants. Journal of Medicinal Chemistry. 64(22). 16746–16769. 13 indexed citations
3.
Wifling, David, Harald Hübner, Günther Bernhardt, et al.. (2020). Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor. Journal of Medicinal Chemistry. 63(8). 4133–4154. 13 indexed citations
4.
Wifling, David, et al.. (2020). Water-soluble inhibitors of ABCG2 (BCRP) – A fragment-based and computational approach. European Journal of Medicinal Chemistry. 210. 112958–112958. 14 indexed citations
5.
Wifling, David, et al.. (2020). Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist. Journal of Medicinal Chemistry. 63(15). 8198–8215. 11 indexed citations
6.
Grätz, Lukas, et al.. (2020). UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors. Journal of Medicinal Chemistry. 63(10). 5297–5311. 22 indexed citations
7.
Wifling, David, et al.. (2019). Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M2R Selectivity. Journal of Medicinal Chemistry. 62(11). 5358–5369. 10 indexed citations
8.
Wifling, David, et al.. (2019). Universal Activation Index for Class A GPCRs. Journal of Chemical Information and Modeling. 59(9). 3938–3945. 18 indexed citations
9.
Wifling, David, Christopher Pfleger, Jonas Kaindl, et al.. (2019). Basal Histamine H4 Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif. Chemistry - A European Journal. 25(64). 14613–14624. 7 indexed citations
10.
Pockes, Steffen, David Wifling, Armin Buschauer, & Sigurd Elz. (2019). Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands†. ChemistryOpen. 8(3). 285–297. 4 indexed citations
11.
Pockes, Steffen, David Wifling, Max Keller, Armin Buschauer, & Sigurd Elz. (2018). Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine H2 Receptor Agonists. ACS Omega. 3(3). 2865–2882. 23 indexed citations
12.
Wifling, David, et al.. (2017). Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M2 Muscarinic Acetylcholine Receptor. Journal of Medicinal Chemistry. 60(8). 3314–3334. 20 indexed citations
13.
14.
Wifling, David, Günther Bernhardt, Stefan Dove, & Armin Buschauer. (2015). The Extracellular Loop 2 (ECL2) of the Human Histamine H4 Receptor Substantially Contributes to Ligand Binding and Constitutive Activity. PLoS ONE. 10(1). e0117185–e0117185. 29 indexed citations
15.
Wifling, David, et al.. (2014). Molecular determinants for the high constitutive activity of the human histamineH4receptor: functional studies on orthologues and mutants. British Journal of Pharmacology. 172(3). 785–798. 29 indexed citations
16.
Wifling, David, David Schnell, Günther Bernhardt, et al.. (2013). Luciferase Reporter Gene Assay on Human, Murine and Rat Histamine H4 Receptor Orthologs: Correlations and Discrepancies between Distal and Proximal Readouts. PLoS ONE. 8(9). e73961–e73961. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joëlle Goulding Breakdown of academic impact, for papers by Heng B. See Breakdown of academic impact, for papers by Mark Soave Breakdown of academic impact, for papers by Changxiu Qu Breakdown of academic impact, for papers by Shane C. Wright Breakdown of academic impact, for papers by John Frazer Breakdown of academic impact, for papers by Yangxia Tan Breakdown of academic impact, for papers by Tamara Miljuš Breakdown of academic impact, for papers by Lukas Grätz Breakdown of academic impact, for papers by Timo Littmann
Rankless by CCL
2026